Hospital of the University of Pennsylvania
Pathology residency · Philadelphia, PA · Program website
- 0
- Faculty
- 44
- Trainees
- 104
- Papers
- 34%
- Trainees published
- 39%
- First author
11 people are awaiting a match decision, so numbers may change.
Papers
By this program's faculty and trainees since 2022, 104 in all. Updated 2026-11-07.
- Fatal Disseminated Powassan Virus Infection in Transplant Recipient, Pennsylvania, USADerek C. Sung et al. · Emerging infectious diseases · 2026
- Acute Erythroid Leukemia Associated With Myeloid Neoplasms: Clinicopathologic Features and Evidence of Clonal ContinuityMegan J. Fitzpatrick et al. · Modern Pathology · 2026 · PubMed
- The RobinCar Family: R tools for robust covariate adjustment in randomized clinical trialsMarlena S. Bannick et al. · BMC Medical Research Methodology · 2026
- Diagnosing Squamous Lesions of Head and Neck: Categorization, Risk of Malignancy, and Follow-Up: An Institutional ExperienceOlivia J. Leung et al. · Acta Cytologica · 2026 · PubMed
- A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trialJason Xu et al. · Nature Medicine · 2026 · PubMed · cited 1
- Penile Intraepithelial Neoplasia and Squamous Cell Carcinoma: A Contemporary Review of Clinicopathologic Features, Classification, and PrognosticationMatthew H. Lanehart et al. · American Journal of Dermatopathology · 2026 · PubMed
- Decade-long persistence of CD19 CAR T cells in B cell lymphomasLuca Paruzzo et al. · Nature Medicine · 2026 · PubMed · cited 3
- A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirectionÁngel Ramírez-Fernández et al. · Journal of Hematology & Oncology · 2026 · PubMed
- Pathology-CoT: learning visual chain-of-thought agents from expert whole-slide image diagnosis behaviourSheng Wang et al. · Nature Biomedical Engineering · 2026 · PubMed · cited 10
- Crumpled cytoplasm, clear diagnosis: the iconic morphology of Gaucher diseaseDerek C. Sung et al. · Blood · 2026 · PubMed
How trainees publishauthor positions, faculty co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 16 of 44 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|
44 trainees are counted above but never listed by name.
About University of Pennsylvaniainstitution-wide pathology research
Pathology publications from University of Pennsylvania and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
Works per year · * 2026 so far
Pathology research topics at University of Pennsylvania
Papers in the window; each links to the list on OpenAlex.
- Multiple Sclerosis Research Studies 236
- Lymphoma Diagnosis and Treatment 193
- Spine and Intervertebral Disc Pathology 126
- Genetic factors in colorectal cancer 50
- Systemic Sclerosis and Related Diseases 42
- Autoimmune Bullous Skin Diseases 36
- Breast Lesions and Carcinomas 29
- Ophthalmology and Eye Disorders 29
Most cited at University of Pennsylvania since 2024
All pathology papers there on OpenAlex
- Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In OncologyRachel Hodan et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 126
- Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne Haney Cross et al. · JAMA Neurology · 2024 · PubMed · cited 107
- Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapiesLaurie Helen Sehn et al. · Blood · 2024 · PubMed · cited 102
- Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical reviewPatricia K. Coyle et al. · Annals of Clinical and Translational Neurology · 2024 · PubMed · cited 70
- Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II StudyLihua Elizabeth Budde et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 67
- Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 studyPier Luigi Zinzani et al. · The Lancet Oncology · 2024 · PubMed · cited 61
- Early management of adult traumatic spinal cord injury in patients with polytrauma: a consensus and clinical recommendations jointly developed by the World Society of Emergency Surgery (WSES) & the European Association of Neurosurgical Societies (EANS)Edoardo Picetti et al. · World Journal of Emergency Surgery · 2024 · PubMed · cited 55
- Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosisRui Li et al. · Science Immunology · 2024 · PubMed · cited 50
- Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor Brooks et al. · Blood · 2025 · PubMed · cited 45
- Advancing multiple sclerosis management in older adultsAnneke van der Walt et al. · Nature Reviews Neurology · 2025 · PubMed · cited 40